(Approval lapsed) Panzytrat 25,000 Pancreatin capsule vial (Allergan)
Section 19A approved medicine
(Approval lapsed) Panzytrat 25,000 Pancreatin capsule vial (Allergan)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
PANZYTRAT 25000 Pancrelipase capsule bottle - AUST R 55941
Indication(s)
For pancreatic enzyme replacement in patients aged 18 months or more suffering with conditions associated with pancreatic exocrine insufficiency such as cystic fibrosis, chronic pancreatitis, post pancreatectomy, post-gastrointestinal bypass surgery (e.g. Billroth II gastroenterostomy) and ductal obstruction.
Images
